Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1995-05-02
1996-01-02
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, A61K 3821
Patent
active
054806402
ABSTRACT:
Described is a method for treating carcinoma of the prostate using recombinant human alpha interferon via intraprostatic or intralesional injection.
REFERENCES:
patent: 4503035 (1985-03-01), Pestka et al.
patent: 4846782 (1989-07-01), Bonner
patent: 4997645 (1991-03-01), Suzuki et al.
patent: 5256410 (1993-10-01), Tanner et al.
Horoszewicz, et al., J. Urology, 142, 1173-1180 (1989).
van Haelst-Pisani, et al., Cancer, 70, (No. 9) 2310-2312 (1992).
van Moorselaar, et al., The Prostate, 18, 331-344 (1991).
Okutani, et al., The Prostate, 18, 73-80 (1991).
Ernstoff, et al., Proc. Amer. Assoc. Cancer Res., 34, 204 (1993).
Chang, et al., J. Interferon Res., 6, 713-715 (1986).
Sica, et al., Urol. Res., 17, 111-115 (1989).
Dreicer, et al., Urology, 44, (No. 3) 377-380 (1994).
Pummer, et al., Eur. Urol., 24, (Suppl. 2) 81-86 (1993).
Medenica, et al., Cancer Drug Delivery, 2, (No. 1) 53-76 (1985).
Jindal, et al., Urol. Int., 52, 225-227 (1994).
Dell'Acqua, et al., J. Tumor Marker Oncol., 5, (No. 3) 269 (1990).
Sica, et al., Urol. Res., 22, 33-38 (1994).
Wickramasinghe et al, J. Am. Acad. Dermatol. 20: 71-74 (1989).
Grob et al, Lancet, 1, 878-879 (1988).
Morales Alvaro
Wilson James W. L.
Schain Howard E.
Schering Corporation
Thompson Paul A.
LandOfFree
Alpha interferon for treating prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha interferon for treating prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha interferon for treating prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-233475